Trial Profile
CORRELATION BETWEEN SHORT- AND LONG-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 18 Apr 2017 New trial record